YD Bio (YDES) Receivables - Net (2024 - 2026)
YD Bio's Receivables - Net was $223,067 in the quarter ended Jun 30, 2026, up 119.9% from $101,430 a year earlier.
Analysis
YD Bio (YDES) Receivables - Net (2024 - 2026) Analysis & Trends
As of Dec 31, 2025, Receivables - Net at YD Bio came in at $167,477, up 93.4% from the prior year.
- In earlier years, Receivables - Net was $86,582 in the year ended Dec 31, 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn |
| 10 | YD Bio | 417.66 Mn | 405.39 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 223,067.00 |
| Dec 31, 2025 | 167,477.00 |
| Jun 30, 2025 | 101,430.00 |
| Dec 31, 2024 | 86,582.00 |
API Access
YD Bio Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=YDES&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "YDES", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=YDES&period=max&api_key=YOUR_API_KEY");
const data = await res.json();